Showing 1991-2000 of 2314 results for "".
- Pfizer CEO Predicts Third COVID-19 Vaccine Booster “Likely” Needed Within Yearhttps://modernod.com/news/pfizer-ceo-predicts-third-covid-19-vaccine-booster-likely-needed-within-year/2479086/Pfizer CEO Albert Bourla believes it will probably be necessary for people to receive yet another dose of COVID-19 vaccine within a year of being fully vaccinated in order to stave off infection, according to recent taped comments that were made public on Thursday. “There will be likely a n
- Essilor to Present New Results for its Stellest Lens for Children With Myopiahttps://modernod.com/news/essilor-to-present-new-results-for-its-stellest-lens-for-children-with-myopia/2479062/Essilor will unveil pivotal 2-year clinical trial results of its Stellest lens for myopia. The 2-year results demonstrate that Essilor Stellest lenses slow down myopia progression by 67% on average, when compared to single vision lenses, when worn at least 12 hours a day,1 according to
- LumiThera Announces Topline Data in the European Multicenter LIGHTSITE II Study to Treat Dry AMDhttps://modernod.com/news/lumithera-announces-topline-data-in-the-european-multicenter-lightsite-ii-study-to-treat-dry-amd/2479059/LumiThera announced positive findings in its LIGHTSITE II multicenter clinical trial in dry age-related macular degeneration (AMD) patients. The prospective, double-masked, randomized, multicenter, European Union post-marketing clinical trial, titled LIGHTSITE II, was conducted in eight re
- Johnson & Johnson Takes Charge of Emergent COVID-19 Vaccine Manufacturing Sitehttps://modernod.com/news/johnson-johnson-takes-charge-of-emergent-covid-19-vaccine-manufacturing-site/2479052/The US Department of Health & Human Services (HHS) has put Johnson & Johnson in charge of the Emergent BioSolutions’ Bayview facility in Baltimore, which ruined around 15 million doses of its COVID-19 vaccine Ad26.COV2.S. Johnson & Johnson said it was “assuming full
- Johnson & Johnson Begins Testing COVID-19 Vaccine in Adolescentshttps://modernod.com/news/johnson-johnson-begins-testing-covid-19-vaccine-in-adolescents/2479045/Johnson & Johnson announced that it has begun vaccinating adolescent participants in an ongoing phase 2a trial of its COVID-19 vaccine candidate Ad26.COV2.S. The study, which got under way last September, was initially designed to evaluate single- and two-dose regimens of the vaccine in healt
- AdaptDx Pro’s On-Board AI Technician Now Speaks in Multiple Languageshttps://modernod.com/news/adaptdx-pros-on-board-ai-technician-now-speaks-in-multiple-languages/2479039/MacuLogix announced its first major software upgrade for its AdaptDx Pro portable dark adaptometer. Once the software is automatically downloaded and installed, the artificial intelligence-driven onboard technician, T
- Pfizer, Moderna COVID-19 Vaccines Show High Efficacy in First US Real-World Studyhttps://modernod.com/news/pfizer-moderna-covid-19-vaccines-show-high-efficacy-in-first-us-real-world-study/2479028/New data released Monday from a US Centers for Disease Control and Prevention (CDC) study of vaccinated health care workers show that mRNA-based coronavirus vaccines by Pfizer and Moderna were 80% effective at preventing infections after one dose, with efficacy climbing to 90% 2 weeks after the s
- Moderna Gives First Vaccine Shots To Young Kids As Part Of COVID-19 Studyhttps://modernod.com/news/moderna-gives-first-vaccine-shots-to-young-kids-as-part-of-covid-19-study/2478978/Children have now received their first doses of Moderna’s COVID-19 vaccine, as the company studies the safety and effectiveness of the vaccine for kids ages 6 months to less than 12 years old, according to an NPR
- Magewell Video Capture Devices Help Non-Profit Eyecare Organization Remotely Train Retinal Surgeons Worldwidehttps://modernod.com/news/magewell-video-capture-devices-help-non-profit-eyecare-organization-remotely-train-retinal-surgeons-worldwide/2478975/Telemedicine workflows incorporating live video have taken on dramatically greater importance for surgical education during the COVID-19 pandemic, as doctors reduce non-essential personnel in their operating rooms for the safety of patients and staff. Needing a way to continue its mission of impr
- New iCare HOME2 Self-Tonometer Enables Eye Pressure Measurement by Glaucoma Patientshttps://modernod.com/news/new-icare-home2-self-tonometer-enables-accurate-eye-pressure-measurement-by-glaucoma-patients/2478976/Icare Finland is launching their next generation self-tonometer, the iCare HOME2. iCare HOME2 provides ease of use and accuracy in monitoring real-world IOP behavior outside of the doctor’s office and clinical hours, supporting glaucoma management, according to a company news release